Basic/Clinical Science Session
CKD-MBD in the Era of Personalized Medicine: Is a New Paradigm Coming? Including the Jack W. Coburn, MD, Endowed Lectureship
October 23, 2020 | 02:30 PM - 04:30 PM
Location: Live-Streamed
Session Description
Renal osteodystrophy (ROD) is a complex disease resulting in increased fractures and mortality. Management should focus on therapy tailored to the underlying bone disease (i.e., ROD-type). However, in most cases, it is not possible to obtain an invasive bone biopsy. This session reviews state-of-the art personalized medicine advancements that may lead to noninvasive approaches for diagnosing, managing, and treating ROD and CKD-associated fractures.
ASN gratefully acknowledges Amgen for support of the Jack W. Coburn, MD, Endowed Lectureship.
Learning Objective(s)
- Describe the current limitations of noninvasive assessments of bone disease in patients with CKD
- Discuss novel approaches that may lead to novel diagnostic strategies
- Explain the importance of bone compartments on ROD pathophysiology
- Identify practical approaches to diagnosing and managing bone disease in the current era
Learning Pathway(s)
- Bone and Mineral Metabolism
- Chronic Kidney Disease
Moderators
- Charles Ginsberg, MD
- Fabrice Mac-Way, MD
Presentations
-
Rationale for Personalized Medicine Approaches to the Management of CKD-Associated Osteoporosis: The Jack W. Coburn, MD, Endowed Lectureship
02:30 PM - 03:00 PM
Glenn Matthew Chertow, MD, MPH, FASN
-
A Personalized, Targeted Approach to Manage Osteoporosis in CKD: A Randomized Clinical Trial Synopsis
03:00 PM - 03:30 PM
Hartmut H. Malluche, MD
-
Single-Cell Methods as a Tool to Redefine Renal Osteodystrophy and Design Future Therapeutics
03:30 PM - 04:00 PM
Valentin David, MS, PhD
-
Bone-Tissue Level Gene Expression to Guide Management of Post-Transplant Bone Disease
04:00 PM - 04:30 PM
Rosa M.A. Moyses, MD, PhD
